Yiwei Dong
Shanghai, 200000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
FBXO2 promotes hepatocellular carcinoma progression and sorafenib resistance by targeting USP49 for proteasomal degradation.
Journal: Frontiers in immunology
Published: July 05, 2025
FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer.
Journal: Journal of translational medicine
Published: November 10, 2022
CXCR4-modified CAR-T cells suppresses MDSCs recruitment via STAT3/NF-κB/SDF-1α axis to enhance efficacy against pancreatic cancer.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: October 12, 2022
Chimeric anti-GPC3 sFv-CD3ε receptor-modified T cells with IL7 co-expression for the treatment of solid tumors.
Journal: Molecular therapy oncolytics
Published: December 08, 2021
Study of the G Protein Nucleolar 2 Value in Liver Hepatocellular Carcinoma Treatment and Prognosis.
Journal: BioMed research international
Published: May 10, 2021
Coexpression of IL7 and CCL21 Increases Efficacy of CAR-T Cells in Solid Tumors without Requiring Preconditioned Lymphodepletion.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 27, 2020
Target-Dependent Expression of IL12 by synNotch Receptor-Engineered NK92 Cells Increases the Antitumor Activities of CAR-T Cells.
Journal: Frontiers in oncology
Published: July 04, 2019
SIN3B promotes integrin αV subunit gene transcription and cell migration of hepatocellular carcinoma.
Journal: Journal of molecular cell biology
Published: January 03, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026